Kidney International Supplements - Table of Contents alert Volume 2 Issue 5

KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole Food Company, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa Hakko Kirin, NATCO—The Organization for Transplant Professionals, NKF-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical, Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma, and Wyeth. TABLE OF CONTENTS Volume 2, Issue 5 (December 2012) In this issue Preface Contents Appendix Biomarker Services for Early and Sensitive Detection of Kidney Damage. Myriad RBM's Rat & Human KidneyMAP® panels enable drug developers to efficiently prioritize medicinal chemistry programs and accelerate decisions on pre-clinical and clinical trial protocols. Click Here to download our White Paper and receive 10% off your next order. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Curing Kidney Disease Thank you to all of you who came to visit the NPG booth at ASN in San Diego. As part of the theme 'Curing Kidney Disease' here are some articles from Kidney International: Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease   Preface Top Notice Kidney inter., Suppl. 2012 2: 337; 10.1038/kisup.2012.46 Full Text | PDF Foreword Kidney inter., Suppl. 2012 2: 338; 10.1038/kisup.2012.47 Full Text | PDF Work Group Membership Kidney inter., Suppl. 2012 2: 339; 10.1038/kisup.2012.48 Full Text | PDF Abstract Kidney inter., Suppl. 2012 2: 340; 10.1038/kisup.2012.49 Full Text | PDF Summary of Recommendation Statements Kidney inter., Suppl. 2012 2: 341-342; 10.1038/kisup.2012.50 Full Text | PDF Contents Top Chapter 1: Introduction Kidney inter., Suppl. 2012 2: 343-346; 10.1038/kisup.2012.51 Full Text | PDF Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients Kidney inter., Suppl. 2012 2: 347-356; 10.1038/kisup.2012.52 Full Text | PDF Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus Kidney inter., Suppl. 2012 2: 357-362; 10.1038/kisup.2012.53 Full Text | PDF Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus Kidney inter., Suppl. 2012 2: 363-369; 10.1038/kisup.2012.54 Full Text | PDF Chapter 5: Blood pressure management in kidney transplant recipients (CKD T) Kidney inter., Suppl. 2012 2: 370-371; 10.1038/kisup.2012.55 Full Text | PDF Chapter 6: Blood pressure management in children with CKD ND Kidney inter., Suppl. 2012 2: 372-376; 10.1038/kisup.2012.56 Full Text | PDF Chapter 7: Blood pressure management in elderly persons with CKD ND Kidney inter., Suppl. 2012 2: 377-381; 10.1038/kisup.2012.57 Full Text | PDF Chapter 8: Future directions and controversies Kidney inter., Suppl. 2012 2: 382-387; 10.1038/kisup.2012.58 Full Text | PDF Appendix Top Methods for guideline development Kidney inter., Suppl. 2012 2: 388-397; 10.1038/kisup.2012.59 Full Text | PDF Biographic and disclosure information Kidney inter., Suppl. 2012 2: 398-403; 10.1038/kisup.2012.60 Full Text | PDF Acknowledgments Kidney inter., Suppl. 2012 2: 404; 10.1038/kisup.2012.61 Full Text | PDF References Kidney inter., Suppl. 2012 2: 405-414; 10.1038/kisup.2012.62 Full Text | PDF Advertisement Kidney International - New Impact Factor The 2011 ISI impact factor for Kidney International is 6.606*, according to the ISI Journal Citation Reports®. This places Kidney International among the top 3 primary research journals in nephrology. Submit your article today! *2011 Journal Citation Reports® (Thomson Reuters, 2012)   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International Supplements. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.